Key Market Indicators
**Swiss Vaccination Coverage to Remain Steady at 96% for 1-Year-Olds by 2028** The Swiss vaccination coverage for children aged one year is projected to remain steady at 96% by 2028, unchanged from 2023. The market has maintained this stability since 1991, reflecting the consistent healthcare efforts in the country. **Swiss Vaccine Imports to Rise to $139 Million by 2028** Switzerland's vaccine imports are expected to grow to approximately $139 million by 2028, up from about $124 million in 2023. This represents an average annual growth rate of 1.7%. Since 1993, the demand for vaccines in Switzerland has seen a steady increase, with a year-on-year growth rate of 5.7%. **Swiss Vaccine Exports to Decline Slightly by 2028** Conversely, Swiss vaccine exports are projected to decline slightly, reaching around $80 million by 2028 from roughly $82 million in 2023. This marks a compound annual growth rate (CAGR) decrease of 0.7% per year. Despite this decline, the Swiss vaccine supply has experienced a modest increase of 0.4% annually since 1993. In 2023, Switzerland ranked 20th globally in vaccine exports, with Indonesia surpassing it at approximately $82 million. Belgium, the United Kingdom, and France occupied the second, third, and fourth positions, respectively, in the same ranking.
